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Global outbreaks of severe acute respiratory distress
syndrome (SARS) in 2003 demonstrated the potential of
healthcare facilities to serve as amplifiers of a new com-
municable disease. However, healthcare settings can also
be amplifiers of multidrug-resistant bacteria and blood-
borne viruses.
In the public health and healthcare delivery systems,
amplifying forces include weaknesses in communication,
coordination, early detection and control of emerging dis-
eases, and oversight of healthcare services. Among health-
care personnel, weaknesses include gaps in infection
control knowledge and practice. 
SARS was spread globally by relatively few people and
amplified by super-spreading events that occurred primari-
ly in healthcare settings. Healthcare personnel were dis-
proportionately affected, accounting for up to 57% of
cases in some countries. The combination of increasing
infectivity in the later stages of SARS, performance of the
aerosol-generating procedures (bronchoscopy, intubation),
and clustering of SARS patients further enhanced trans-
mission of the SARS-associated coronavirus. 
Systems for early detection and isolation of persons
with suspected SARS and public quarantine effectively
reduced transmission. Conversely, absence of control
measures at initial points of patient encounter, particularly
in hospital emergency departments, rendered hospitals par-
ticularly vulnerable to SARS transmission. 
Unsafe injection and blood donation practices have
contributed to the global spread of bloodborne viral dis-
eases. Worldwide, unsafe injections alone are estimated to
cause 21,000 cases of hepatitis B, 2,000 cases of hepatitis
C, and 260 cases of HIV each year. Countries with limited
resources are at a disproportionate risk for adverse injec-
tion-related outcomes. While lack of sterile supplies is
important, unnecessary injections and poor understanding
of infection control principles and practices also contribute
to the spread of bloodborne viruses. These last two factors
are not unique to the developing world. Four recent out-
breaks of hepatitis B and C viruses in patients in ambula-
tory care facilities in the United States are a reminder that
unsafe injections can occur in any healthcare setting. In
these outbreaks, a lack of administrative oversight and
poor understanding of infection control practices con-
tributed to the contamination of multidose vials or the
reuse of injection equipment and transmission of hepatitis
B or hepatitis C virus to numerous patients.
In contrast to SARS and bloodborne viruses, the rise
and amplification of multidrug-resistant organisms in
healthcare settings have been gradual and subtle. These
organisms limit treatment options, increase transmission
risks for vulnerable patient populations, increase illness
and death, prolong the hospital stay, and add to healthcare
costs. The rise of these organisms has been most dramatic
in U.S. intensive care units, where  50% of Staphylococcus
aureus isolates are resistant to methicillin (MRSA) and
25% of enterococcal isolates are resistant to vancomycin.
Cases of vancomycin-intermediate S. aureus and three
recent cases of vancomycin-resistant S. aureus, both in
outpatient settings, attest to the potential for amplification
of these organisms in healthcare settings. Gram-negative
organisms resistant to extended-spectrum β-lactamases
present similar concerns and have been associated with
numerous outbreaks in healthcare facilities. 
The problem of multidrug-resistant organisms is multi-
faceted. While colonized and infected patients constitute
the major reservoir for dissemination of these organisms,
inappropriate use or overuse of antimicrobial agents con-
tributes to acquiring and expressing resistance genes.
Healthcare settings become breeding grounds of addition-
al resistance and distribution centers for amplification of
multidrug-resistant organisms to other healthcare settings
and the community.
The notion that our healthcare settings contribute to the
amplification of infectious disease contradicts our expecta-
tions. Usually, healthcare systems work well, and quality
healthcare is delivered safely and efficiently. Nonetheless,
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that can open the door to disease outbreaks. 
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Transformation of the
Developing World:
Socioeconomic Matrix
1
Economic disparity affects the health of persons around
the world, and various societal, environmental, and eco-
nomic factors influence the emergence of infectious dis-
eases. Similarly, emerging infectious diseases have a social
and economic impact, including diminished economic pro-
ductivity, increased expenditures on public heath, deferred
external investment and development, and reduced travel
and retail sales.
The thriving consumer demand for exotic and rare ani-
mals as “tonic” food in China, especially in the southern
regions, raises concern for the risk for animal-human
cross-infections through contact with live and recently
slaughtered animals. The increased demand for civet cat,
suspected as the source of severe acute respiratory syn-
drome, is one such example. The demand for tonic food
has risen with improving economic conditions in post-
1978 China and is a form of conspicuous consumption that
expresses economic and social distinction and prestige. A
Chinese medical paradigm based on “humors” inherent in
the concept of tonic food, combined with the well-under-
stood cultural symbolism of distinction and prestige asso-
ciated with conspicuous consumption, has lent weight to
the demand for rare and exotic animals perceived to be
“pure,” “safe,” and “virile.” Since this rising demand is not
likely to be suppressible, regulated production of these ani-
mals is needed to make them safe. 
Additional contemporary issues in China include the
effect of migration and urbanization on the spread of sex-
ually transmitted diseases. The forces driving this effect
can be divided into three overlapping categories: the dis-
mantling of the organizational and spatial structures that
helped keep order in China's cities during the Maoist era
(from 1949 to 1978); a dramatic increase in the overall flu-
idity of urban societies in China (accompanied by the ero-
sion of traditional moral and behavioral boundaries); and a
new set of cultural values that has encouraged more urban
Chinese to think of themselves as actors with individual
agency. These overlapping forces, which are geographic,
socioeconomic, and cultural, are interwoven with and thor-
oughly implicated in the emergence of new behavior and
lifestyles that have put a growing number of Chinese at
risk for infectious diseases.
More broadly, climate can also affect public health and
emerging infectious diseases. Factors affecting emergence
can also be examined in an eco-epidemiologic framework
that can often drive epidemics. Examples include the
effects of rains and flooding on vector-borne and diarrheal
diseases and the effect of heat and fires on respiratory
infections.
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Emerging Issues for the
Public Health Laboratory
2
U.S. public health laboratories face challenges from
within and outside the system, including emergence of
new pathogens, introduction of new testing methods, new
security requirements, shortages of well-qualified person-
nel, and collaboration with new partners. 
The public health system depends on hospital and com-
mercial laboratories as major sources of reliable epidemio-
logic information. Thus, the current crisis in these
laboratories is of great concern. The pressures come from
the need to address emerging infectious diseases, detect
antimicrobial resistance, and recognize potential agents of
bioterrorism while updating procedures, practices, and
facilities to meet new biosafety, biosecurity, confidentiality,
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